{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-000765","form_type":"8-K","ticker":"TGNT","cik":"0000846377","company_name":"Totaligent, Inc.","filed_at":"2026-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.815947+00:00","generated_at":"2026-05-16T03:10:15.554408+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Totaligent enters acqui-hire LOI with Aetherium Medical; 10% equity stake, no cash","bullets":["Acquiring Aetherium's team, IP, business plan in exchange for 10% of Totaligent's outstanding common stock as restricted preferred.","New wholly owned subsidiary Aetherium Medical LLC formed; Assets contributed with no cash consideration at closing.","Ivan Klarich, Aetherium's CEO, appointed Managing Director of the subsidiary.","Target closing March 5, 2026; exclusivity through April 5, 2026; definitive agreements to follow.","Equity subject to milestone-based vesting, 15% escrow holdback for 12 months, and repurchase rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-000765","json":"https://secwatch.observer/filing/0001477932-26-000765.json","markdown":"https://secwatch.observer/filing/0001477932-26-000765.md","text":"https://secwatch.observer/filing/0001477932-26-000765.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/846377/000147793226000765/0001477932-26-000765-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846377/000147793226000765/totaligent_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:10:15.554408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c6bebf7b99122f93a1b6922b14f9a1c034a1ab3c","claim":"Totaligent, Inc. entered into Binding Letter of Intent with Aetherium Medical (effective 2026-02-11).","evidence_excerpt":"On February 11, 2026, Totaligent, Inc. (the “Company”) entered into a Binding Letter of Intent (the “LOI”) with Aetherium Medical (“Aetherium”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/846377/000147793226000765/0001477932-26-000765-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Aetherium Medical"},{"label":"Effective","value":"2026-02-11"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}